SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-008136
Filing Date
2020-05-20
Accepted
2020-05-20 17:20:04
Documents
3
Period of Report
2020-05-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2020q18k-earningsrelease.htm 8-K 37504
2 EXHIBIT 99.1 a2020q1-ex991earningsrelea.htm EX-99.1 265881
3 cumberlandpharmaimageaa06.jpg GRAPHIC 37721
  Complete submission text file 0001628280-20-008136.txt   356586
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 20899024
SIC: 2834 Pharmaceutical Preparations